SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)

Garcia-Saenz, Jose Angel; Blancas, Isabel; Echavarria, Isabel; HINOJO, CARMEN; Margeli Vila, Mireia; Moreno, Fernando; Bellet Ezquerra, Meritxell

View

SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022), 2023 (1.397Mb)

Author

Garcia-Saenz, Jose Angel

Bellet Ezquerra, Meritxell

Date

2023-09

Permanent link

https://hdl.handle.net/11351/10245

DOI

10.1007/s12094-023-03203-8

ISSN

1699-3055

WOS

000982749400001

PMID

37148499

Show full item record

Abstract

Advanced breast cancer represents a challenge for patients and for physicians due its dynamic genomic changes yielding to a resistance to treatments. The main goal is to improve quality of live and survival of the patients through the most appropriate subsequent therapies based on the knowledge of the natural history of the disease. In these guidelines, we summarize current evidence and available therapies for the medical management of advanced breast cancer.

Keywords

Advanced breast cancer; Anti-HER2 therapy; Endocrine therapy

Bibliographic citation

Garcia-Saenz JA, Blancas I, Echavarria I, Hinojo C, Margeli M, Moreno F, et al. SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022). Clin Transl Oncol. 2023 Sep;25:2665–78.